checkAd

     295  0 Kommentare AgraFlora Subsidiary Farmako Receives Special License Permitting the Sale of Irradiated Medical Cannabis - Seite 2

    Management believes Farmako has achieved a market share of approximately 8 per-cent of the German medical market. But with the patient population growing 12,400 per-cent since 2017 and the restrictions on sterilized cannabis flowers, Farmako has been unable to capture additional growth. With the additional license in hand, Farmako intends on rapidly expanding its international vendor network to increase its revenues and EBIT earned in the German market in 2020. 

    About Farmako GmbH
    Farmako is one of Europe’s leading distributors of medical cannabis with active revenue-generating operations in Germany, Europe’s largest medicinal cannabis market. In 2020, Farmako expects to be one of the first, fully licensed distributors of medical cannabis in the United Kingdom. The Company is also pursuing medical cannabis distribution operations in Luxembourg and Denmark, two of Europe’s fastest emerging medical cannabis markets. For more information please visit: https://www.farmako-global.com/.

    About AgraFlora Organics International Inc.

    AgraFlora Organics International Inc. is a leading cannabis company building shareholder value through the development of revenue generating operating assets in the global cannabis industry. AgraFlora is focused primarily on the Canadian cannabis industry; the world’s most advanced and regulated legal cannabis market. Flagship Canadian assets include: Edibles & Infusions, a fully automated manufacturing facility in Winnipeg, MB for white-label and consumer branded edible production; Propagation Services Canada, a large-scale commercial greenhouse in Delta, BC focused on reshaping the Canadian flower market with high-potency, low cost cannabis flower, and AAA Heidelberg, a craft focused cannabis producer in London, ON. In addition, AgraFlora’s wholly owned subsidiary Farmako GmbH is scaling towards its goal of being Europe’s leading distributor of medical cannabis. Farmako currently has active distribution operations in Germany and expects to commence active operations in the United Kingdom in 2020. For more information please visit: https://agraflora.com/.

    ON BEHALF OF THE BOARD OF DIRECTORS

    Brandon Boddy
    Chairman & CEO
    T: (604) 398-3147 

    For additional information:

    AgraFlora Organics International Inc.
    Tim McNulty
    E: ir@agraflora.com
    T: (800) 783-6056
     

    For French inquiries:
    Remy Scalabrini, Maricom Inc.
    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    AgraFlora Subsidiary Farmako Receives Special License Permitting the Sale of Irradiated Medical Cannabis - Seite 2 VANCOUVER, British Columbia, Feb. 18, 2020 (GLOBE NEWSWIRE) - AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is …